Fibrocell Science gains on positive results from stem cell study

Fibrocell Science (FCSC +1.7%) moves up today after saying it's had positive results from a study into a potential mechanism for converting research-grade adult skin cells into clinical grade induced pluripotent stem cells.

The study also confirms that researchers can remove unwanted non-human contaminants from stem cell populations derived under research-grade conditions.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs